Cargando…
Enhanced Patient-Centricity: How the Biopharmaceutical Industry Is Optimizing Patient Care through AI/ML/DL
Technologies utilizing cutting-edge methodologies, including artificial intelligence (AI), machine learning (ML) and deep learning (DL), present powerful opportunities to help evaluate, predict, and improve patient outcomes by drawing insights from real-world data (RWD) generated during medical care...
Autores principales: | Zou, Kelly H., Li, Jim Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602573/ https://www.ncbi.nlm.nih.gov/pubmed/36292444 http://dx.doi.org/10.3390/healthcare10101997 |
Ejemplares similares
-
Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
por: Baronikova, Slavka, et al.
Publicado: (2019) -
Editorial: ML and AI Safety, Effectiveness and Explainability in Healthcare
por: Benrimoh, David, et al.
Publicado: (2021) -
Risk-Return Analysis of the Biopharmaceutical Industry as Compared to Other Industries
por: Popa, Cedric, et al.
Publicado: (2018) -
Hybrid SFNet Model for Bone Fracture Detection and Classification Using ML/DL
por: Yadav, Dhirendra Prasad, et al.
Publicado: (2022) -
Argumentation: A calculus for Human-Centric AI
por: Dietz, Emmanuelle, et al.
Publicado: (2022)